Innovations in Generics, India Conference 2010 at Nextgen, Mumbai
Introduction: There is no denying that the pipeline of off-patent molecules is now seriously drying up! To continue the impressive growth of the pharma industry, companies must drive innovation through their generic products and market development strategies.
But this is no easy task! Leveraging new drug delivery systems, exploiting the potential of nanotechnology, adopting novel formulation and combination strategies are just some of the routes to improved generic product development. But just how aware are you of the regulatory and commercial implications of adopting these approaches to drive super generics?
Attend NextGen 2010 in Mumbai, India, and gain in-depth answers to these complex questions. This programme has been researched in great depth with representatives of the local and international pharmaceutical industry to bring you two intensive days of insights, analyses, benchmarking and facilitated networking.
Just some of the highlights of the conference include:
* Case Study Presentations – from Ranbaxy, Dr. Reddy’s Laboratories, Sun Pharmaceuticals, GlaxoSmithKline, Teva, Merck, Reliance Life Sciences, amongst others.
* In-Depth Analysis – of the technical challenges, marketing opportunities, partnership options, and pricing and promotion strategies.
* Regulatory Guidance – on both the evolving domestic scenario and the ever stringent international requirements.
Conference Venue:
The Westin Mumbai Garden City
International Business Park
Oberoi Garden City
Goregaon (East)
Mumbai 400063
India
Pricing:
Indian Delegate @ INR.35,000 + 10.3% Service Tax = INR.38,605
International Delegate @ $1,395 + 10.3% Service Tax = $1,538.69
Conference Dates: 24th-25th June, 2010
Online Registration: For Online Registration Click http://www.nextgen-2010.com/register.asp
Email: conferences(AT)ubmindia.com
Contact Number: +91 (0)22 4046 1466
Source: http://www.nextgen-2010.com/
No comments:
Post a Comment